TELO2 and glioblastoma: We find elevated levels of the canonical telomerase pathway genes; RTEL1, TELO2, and TERT expressed in this cohort, and it has been previously been shown that elevated levels of TERC, TERT and RTEL1, correlated with poor outcome in GBM [89].